Back to search

Schizoaffective disorder: role of atypical antipsychotics

Data up to Jan 2025

Published1999
Citations16
References49

Total Citations Per Year

Abstract

References (49)

Clozapine for the Treatment-Resistant Schizophrenic

1988 • 4,030 citations

The Structured Clinical Interview for DSM-III-R (SCID)

1992 • 1,653 citations

Radioreceptor Binding Profile of the Atypical Antipsychotic Olanzapine

1996 • 1,047 citations

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

1997 • 906 citations

Serotonin-dopamine interaction and its relevance to schizophrenia

1996 • 822 citations

Textbook of psychopharmacology

1975 • 583 citations

Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects

1989 • 316 citations

Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.

1995 • 299 citations

Clozapine for treatment-refractory mania

1996 • 269 citations

Depressive Signs and Symptoms in Schizophrenia

1998 • 264 citations

5HT2 receptor changes in major depression

1990 • 261 citations

Platelet serotonin-2 receptor binding sites in depression and suicide

1990 • 223 citations

Regulation of serotonin2 (5-HT2) receptors labeled with [3H]spiroperidol by chronic treatment with the antidepressant amitriptyline.

1980 • 207 citations

Principles and Practice of Psychopharmacotherapy

1993 • 188 citations

Serotonin receptor sensitivity after acute and chronic treatment with mianserin.

1982 • 188 citations

Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia.

1991 • 170 citations

Serotonin 5-HT2 receptor binding on blood platelets - a peripheral marker for depression?

1987 • 170 citations

Hypersensitive Serotonergic Receptors Involved in Clinical Depression—A Theory

1978 • 140 citations

The Genetics of Personality Disorder

1992 • 139 citations

Do Central Antiadrenergic Actions Contribute to the Atypical Properties of Clozapine?

1992 • 130 citations

Clozapine in the treatment of dysphoric mania

1992 • 126 citations

Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up.

1994 • 122 citations

Efficacy of risperidone treatment for psychoses associated with schizophrenia, schizoaffective disorder, bipolar disorder, or senile dementia in 11 geriatric patients: a case series.

1995 • 111 citations

Clozapine in severe mood disorders.

1995 • 104 citations

Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.

1995 • 104 citations

Double-blind Comparison of Risperidone and Haloperidol in Schizophrenic and Schizoaffective Psychoses

1993 • 99 citations

Risperidone in the Treatment of Disorders with a combined Psychotic and Depressive Syndrome - A Functional Approach

1992 • 91 citations

Olanzapine Response in Psychotic Depression

1999 • 89 citations

A double‐blind study of adjunctive carbamazepine versus placebo on excited states of schizophrenic and schizoaffective disorders

1989 • 88 citations

Trials of Lithium, Chlorpromazine and Amitriptyline in Schizoaffective Patients

1978 • 83 citations

Clozapine treatment of nonpsychotic rapid cycling bipolar disorder: A report of three cases

1994 • 76 citations

A Risk-Benefit Assessment of Mirtazapine in the Treatment of Depression

1997 • 75 citations

Neuropharmacology and behavior

1973 • 71 citations

Treatment of Schizoaffective Disorders

1984 • 66 citations

Different effects of serotonin antagonists on 3H-mianserin and 3H-ketanserin recognition sites

1985 • 60 citations

Possible Interaction between Fluoxetine and Pimozide Causing Sinus Bradycardia

1993 • 60 citations

Mania associated with risperidone use.

1996 • 60 citations

ICI 204,636 (SEROQUEL™): A Dibenzothiazepine Atypical Antipsychotic. Review of Preclinical Pharmacology and Highlights of Phase II Clinical Trials

1995 • 51 citations

Pharmacologic treatment of schizoaffective disorder

1994 • 51 citations

Postsynaptic serotonergic blockade following chronic antidepressive treatment with trazodone in an animal model of depression

1984 • 49 citations

Risperidone therapy in treatment refractory acute bipolar and schizoaffective mania.

1996 • 45 citations

The use of carbamazepine in the treatment of schizophrenic and schizoaffective psychoses: a review.

1992 • 40 citations

Molecular biology of serotonin receptors.

1992 • 32 citations

Olanzapine vs placebo in the treatment of acute mania

1998 • 30 citations

Treatment guidelines for valproate in bipolar and schizoaffective disorders.

1993 • 28 citations

The New Antipsychotics and Their Therapeutic Potential

1997 • 17 citations

Olanzapine in the treatment of schizoaffective disorder

1996 • 7 citations

The efficacy of ziprasidone in schizophrenia and schizoaffective disorder: An update

1997 • 4 citations

[Preliminary results of treatment with clozapine and lithium carbonate for manic symptoms in schizoaffective psychosis].

1990 • 2 citations

Cited By (0)

Loading...
Schizoaffective disorder: role of atypical antipsychotics (1999) – Schizophrenia Research | Metascience Observatory Explorer